NSUN3 and NSUN4 have received less attention in prostate cancer research, but they may play a role in chemotherapy resistance and tumor advancement (Alshaker et al., 2019), potentially serving as risk factors for prostate cancer (Kar et al., 2016). This evidence concerns the gene NSUN4 and Familial prostate cancer.